BP003220: Biotinylated Human Peptide Ready HLA-A*24:02&B2M Monomer-Protein with the C-His-Avi Tag
Source: The recombinant Biotinylated Human Peptide Ready HLA-A*24:02&B2M Monomer-Protein, (amino acids Gly25-Thr305(HLA-A*24:02) & Ile21-Met119(B2M)) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Biotinylated Human Peptide Ready HLA-A*24:02&B2M Monomer protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/well) on the streptavidin precoated plate (5 ug/ml). Dose response curve for the recombinant Anti-HLA class I (W6/32) Antibody protein with the C-hFc tag with the EC50 of 4.1 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.PA000097-MA1114: γ-Tubulin Monoclonal Antibody
Mouse Monoclonal Antibody;
Applications: WB;
Reactivity: Human, Rat;
Clone: IMD-20;
Isotype: Mouse IgG1.BP000271-C035: Recombinant Human Interleukin-8 (IL-8) Protein
Source: E. coli-derived.
The ED50 as determined by its chemotaxis of hCXCR-2 transfected mouse BaF/3 cells is less then 2 ng/ml, corresponding to a Specific Activity of 5.0 x 105 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000271-C037: Recombinant Human Interleukin-8 (IL-8) Protein
Source: E. coli-derived.
The ED50 as determined by its chemotaxis of hCXCR-2 transfected mouse BaF/3 cells is less then 2 ng/ml, corresponding to a Specific Activity of 5.0 x 105 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000271-CHM-231: Recombinant Human Interleukin-8 (IL-8) Protein
Source: E. coli-derived.
Specific Activity of IL8 in chemotaxis of donor PBL neutrophils, threshold concentration corresponding to 10-100 ug/ml corresponding to a Specific Activity of 1,000-10,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000271-CHM-327: Recombinant Human Interleukin-8 (IL-8) Protein
Source: E. coli-derived.
Specific Activity of IL8 in chemotaxis of donor PBL neutrophils, threshold concentration corresponding to 25-150 ug/ml corresponding to a Specific Activity of 6,667-40,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000271-CHM-340: Recombinant Porcine Interleukin-8 (IL-8) Protein
Source: E. coli-derived.
The biological activity of IL8 was determined by the dose dependent mobilization of intracellular calcium (calcium flux) with human neutrophils and was found to be >1.0 ug/ml corresponding to a Specific Activity of 1,000,000 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000271-CHM-349: Recombinant Human Interleukin-8 (IL-8) Protein, Pichia
Source: Pichia Pastoris-derived.
Specific Activity of IL8 in chemotaxis of donor PBL neutrophils, threshold concentration of 25 ug/ml corresponding to a Specific Activity of 40,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000271-CHM-004: Recombinant Rhesus Macaque Interleukin-8 (IL-8) Protein
Source: E. coli-derived.
Determined by its ability to chemoattract human peripheral blood neutrophils using a concentration range of 50-150 ng/ml, corresponding to a Specific Activity of 6,667-20,000 IU/mg.
Purity: > 97% by SDS-PAGE.